PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Mounjaro
Presentation Product Chemical substance Chapter Items dispensed
Mounjaro KwikPen 5mg/0.6ml inj 2.4ml pre-filled pens
0601023AZBBAGAG
Mounjaro Tirzepatide Endocrine System 105,198
Mounjaro KwikPen 2.5mg/0.6ml inj 2.4ml pre-filled pens
0601023AZBBAHAH
Mounjaro Tirzepatide Endocrine System 51,586
Mounjaro KwikPen 7.5mg/0.6ml inj 2.4ml pre-filled pens
0601023AZBBACAC
Mounjaro Tirzepatide Endocrine System 24,708
Mounjaro KwikPen 10mg/0.6ml inj 2.4ml pre-filled pens
0601023AZBBAFAF
Mounjaro Tirzepatide Endocrine System 10,826
Mounjaro KwikPen 12.5mg/0.6ml inj 2.4ml pre-filled pens
0601023AZBBAEAE
Mounjaro Tirzepatide Endocrine System 2,198
Mounjaro KwikPen 15mg/0.6ml inj 2.4ml pre-filled pens
0601023AZBBADAD
Mounjaro Tirzepatide Endocrine System 1,993
Mounjaro 2.5mg/0.5ml solution for injection pre-filled pens
0601023AZBBAAAA
Mounjaro Tirzepatide Endocrine System 88
Mounjaro 5mg/0.5ml solution for injection pre-filled pens
0601023AZBBABAB
Mounjaro Tirzepatide Endocrine System 52

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.